14 Mar, 2024 09:58 AM
-- Reported positive preliminary data for CHM 1101 in heavily pretreated glioblastoma patients, confirming advancement to next phase of CHM 1101 development
-- FDA IND clearance for CHM 2101 enabli...read more
05 Mar, 2024 10:39 AM
ParagonCare refers to the proposed merger with CH2 by way of the acquisition of all of the issued share capital in CH2 from the relevant sellers in exchange for issuing approximately 943,524,071 sha...read more
01 Mar, 2024 05:01 PM
S&P Dow Jones Indices announced today the changes in the S&P/ASX Indices, effective prior to the open of trading on Monday, March 18, 2024, as a result of the March quarterly review.
For ...read more
01 Mar, 2024 10:13 AM
A transformative merger between ParagonCare and CH2 creating a leading healthcare wholesaler, distributor and manufacturer operating across growing healthcare markets in the Asia Pacific region.
...read more
01 Mar, 2024 09:25 AM
The securities of the following entities will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Friday, 1 March 2024, for not lodging the relevant periodic ...read more
29 Feb, 2024 09:20 AM
-- First Pancreatic Cancer participant dosed at the Montefiore Medical Center, New York, USA
-- Phase I study of 9 participants is designed to assess the safety and dosimetry of RAD 301
-- A total...read more